Drug Administration Routes

"Drug Administration Routes" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

The various ways of administering a drug or other chemical to a site in a patient or animal from where the chemical is absorbed into the blood and delivered to the target tissue.

Descriptor ID	D004333
MeSH Number(s)	E02.319.267
Concept/Terms	Drug Administration Routes Drug Administration Routes Administration Routes, Drug Administration Route, Drug Drug Administration Route Route, Drug Administration Routes, Drug Administration

Below are MeSH descriptors whose meaning is more general than "Drug Administration Routes".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Therapeutics [E02]
Drug Therapy [E02.319]
Drug Administration Routes [E02.319.267]

Below are MeSH descriptors whose meaning is more specific than "Drug Administration Routes".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Drug Administration Routes" by people in this website by year, and whether "Drug Administration Routes" was a major or minor topic of these publications.

Bar chart showing 13 publications over 9 distinct years, with a maximum of 2 publications in 2001 and 2005 and 2007 and 2011

To see the data from this visualization as text, click here.

Year	Minor Topic	Total
2001	2	2
2003	1	1
2004	1	1
2005	2	2
2007	2	2
2008	1	1
2011	2	2
2016	1	1
2024	1	1

Below are the most recent publications written about "Drug Administration Routes" by people in Profiles.

Gilbert LR, Tawiah NA, Adepoju OE. Exploring racial and secondary substance use differences in route of administration of opioid drugs: Analysis of the 2015-2019 treatment admission data. J Subst Use Addict Treat. 2024 Jul; 162:209365.

View in: PubMed
Shi H, Fang Y, Huang L, Gao L, Lenahan C, Okada T, Travis ZD, Xie S, Tang H, Lu Q, Liu R, Tang J, Cheng Y, Zhang JH. Activation of Galanin Receptor 1 with M617 Attenuates Neuronal Apoptosis via ERK/GSK-3?/TIP60 Pathway After Subarachnoid Hemorrhage in Rats. Neurotherapeutics. 2021 07; 18(3):1905-1921.

View in: PubMed
Roytman M, Ramkissoon R, Wu C, Hong L, Trujillo R, Huddleston L, Poerzgen P, Seto T, Wong L, Tsai N. Examining the clinical course of genotype 1 chronic hepatitis C patients treated with the cosmos regimen: including patients with advanced liver disease and East Asian ancestry. Hepatol Int. 2016 Jul; 10(4):616-23.

View in: PubMed
Arroyo-Novoa CM, Figueroa-Ramos MI, Miaskowski C, Padilla G, Paul SM, Rodr?guez-Ortiz P, Stotts NA, Puntillo KA. Efficacy of small doses of ketamine with morphine to decrease procedural pain responses during open wound care. Clin J Pain. 2011 Sep; 27(7):561-6.

View in: PubMed
Tulloch I, Ghazaryan N, Mexhitaj I, Ordonez D, Angulo JA. Role of neurokinin-1 and dopamine receptors on the striatal methamphetamine-induced proliferation of new cells in mice. Brain Res. 2011 Jul 05; 1399:33-9.

View in: PubMed
Puig-Ramos A, Santiago GS, Segarra AC. U-69593, a kappa opioid receptor agonist, decreases cocaine-induced behavioral sensitization in female rats. Behav Neurosci. 2008 Feb; 122(1):151-60.

View in: PubMed
Merrill GF, Merrill JH, Golfetti R, Jaques KM, Hadzimichalis NS, Baliga SS, Rork TH. Antiarrhythmic properties of acetaminophen in the dog. Exp Biol Med (Maywood). 2007 Oct; 232(9):1245-52.

View in: PubMed
Fort TJ, Garc?a-Crescioni K, Agricola HJ, Brezina V, Miller MW. Regulation of the crab heartbeat by crustacean cardioactive peptide (CCAP): central and peripheral actions. J Neurophysiol. 2007 May; 97(5):3407-20.

View in: PubMed
Todorovic C, Jahn O, Tezval H, Hippel C, Spiess J. The role of CRF receptors in anxiety and depression: implications of the novel CRF1 agonist cortagine. Neurosci Biobehav Rev. 2005; 29(8):1323-33.

View in: PubMed
Byers DM, Irwin LN, Moss DE, Sumaya IC, Hohmann CF. Prenatal exposure to the acetylcholinesterase inhibitor methanesulfonyl fluoride alters forebrain morphology and gene expression. Brain Res Dev Brain Res. 2005 Aug 08; 158(1-2):13-22.

View in: PubMed

People

Explore

Similar Concepts

Top Journals